US agency backs Merck cholesterol drug to lower heart problems in kidney disease patients

WASHINGTON - The U.S. Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug....More